MeiraGTx Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting
April 21, 2023 08:30 ET
|
MeiraGTx
LONDON and NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced two abstract...
UPDATE – Viridian Therapeutics Announces Presentations at the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology
April 20, 2023 13:41 ET
|
Viridian Therapeutics, Inc
- Presentations to cover updated clinical and preclinical data on pipeline candidates in Company’s thyroid eye disease program - - Platform presentation to feature data from ongoing Phase 1/2 trial...
Dry Eye Syndrome Treatment Market Worth US$10.2 Billion by 2033 — Exclusive Report by Persistence Market Research
April 20, 2023 11:35 ET
|
Persistence Market Research
New York, April 20, 2023 (GLOBE NEWSWIRE) -- The Dry Eye Syndrome Treatment Market is expected to generate US$ 4.8 billion in revenue globally in 2022, and is projected to grow at a CAGR of 7.1% to...
Ocugen to Present at Association for Research in Vision and Ophthalmology 2023 Annual Meeting
April 20, 2023 08:00 ET
|
Ocugen
MALVERN, Pa., April 20, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Viridian Therapeutics Announces Presentations at the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology
April 20, 2023 08:00 ET
|
Viridian Therapeutics, Inc
- Presentations to cover updated clinical and preclinical data on pipeline candidates in Company’s thyroid eye disease program - - Platform presentation to feature data from ongoing Phase...
Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress
April 20, 2023 08:00 ET
|
Alimera Sciences, Inc.
ATLANTA, April 20, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners...
Samsung Bioepis to Present New Data for SB15, a proposed biosimilar to Eylea (aflibercept), at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
April 20, 2023 07:00 ET
|
Samsung Bioepis
Final 56-week results from the Phase 3 study for SB15 compared with reference aflibercept in neovascular age-related macular degeneration to be presented, in addition to analytical similarity data...
Fine Medical Wire Market Size To Hit US$ 1.1 billion By 2033, Owing To Increasing Investments in Healthcare Sector Globally | Persistence Market Research
April 19, 2023 11:30 ET
|
Persistence Market Research
New York, April 19, 2023 (GLOBE NEWSWIRE) -- The Fine Medical Wire Market has experienced robust growth in recent years and is expected to continue its upward trajectory in the forecast period. The...
Cognition Therapeutics to Present Analysis Showing Impact of CT1812 on Pathways Implicated in Dry Age-related Macular Degeneration at ARVO 2023
April 19, 2023 07:30 ET
|
Cognition Therapeutics, Inc.
NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX) will be presenting in vitro results characterizing the role of sigma-2 (σ-2) receptors and effect of CT1812...
Clearside Biomedical’s Suprachoroidal Injection Platform to be Featured at The Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting
April 19, 2023 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., April 19, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...